Clinical complications of heterologous antisera administration

von Behring E. Kitasato O. Uber das zustandekommen der diphtherie-immunitat und der tetanus-immunitat. Deutsch Med Wochenschr 1890; 16, 1113

Beclere A. Experimental studies of post-therapeutic lesions. Annales de l’lnstitut Pasteur 1896; 10, 567

Daut M. Zur Statistike der serumexanthene. Jahrb fuer Kinderhailk 1897 289

Starzl E.T. Marchioro T.L. Hutchinson S.E. et al. The clinical use of antilymphocyte globulin in renal hemotransplantation. Transplant 1967; 5, 1100

Bielory L. Gascon P. Bone marrow failure: Immunological implications and treatment modalities. Ann. Allergy 1986; 56, 114–116 123–5

Ritz J. Pesando J.M. Sallan S.E. Clavell L.A. Notis-McConarty J. Rosenthal P. Schlossman S.F. Serotherapy of acute lymphoblastic leukemia with monoclonal antibody. Blood 1981; 58, 141

Brendel W. Lob G. Angstwurm H. Frick E. Prass B. Merlin J. Siefert J. Backmund H. The treatment of autoimmune diseases with ALG. Behring Inst. Mitt 1972; 51, 176

Russell F.E. Snake venom poisoning in the United States. Ann Rev Med 1980; 31, 247

Russell F.E. Treatment of snake bites in the U.S.A. Med Lett Drugs Ther 1982; 24, 87

Lamson R.W. Fatal anaphylaxis and sudden death associated with the injection of foreign substances. JAMA 1924; 82, 1091

James L.P. Austen K.F. Fatal systemic anaphylaxis in man. NEJM 1964; 270, 597

Sheffer A.L. Austen K.F. Exercise induced anaphylaxis. JACI 1980; 66, 106

Wasserman S.I. Mediators of immediate hypersensitivity. JACI 1983; 72, 101

Benveniste J. Platelet-activating factor, a new mediator of anaphylaxis and immune complex deposition from rabbit and human basophils. Nature 1914; 249, 581

Waldbott G.L. Anaphylactic death from penicillin. JAMA 1949; 139, 526

Umetsu D.T. Hahn J.S. Perez-Ataycle A.R. Geha R.S. Serum sickness triggered by anaphylaxis: A complication of immunotherapy. JACI 1985; 76, 713

Fellner M.J. Ball E.H. Barr R.L. Double reaction to penicillin: Anaphylactic and serumsickness like reactions due to a single dose. Arch Derm 1967; 96, 687

O’Connor R. Stier R.A. Rosenbrook W. Erikson R.W. Death from a ‘wasp’ sting. Ann Allergy 1964; 22, 385

Burman D. Hodson A.L. Wood C.B.S. Brueton F.W. Acute anaphylaxis, pulmonary edema, and intravascular hemolysis due to cryoprecipitate. Arch Dis Child 1973; 48, 483

Vyas G.N. Perkins H.A. Yang Y.M. Fudenberg H.H. Health blood donors with selective absence of immunoglobulin A: Prevention of anaphylactic transfusion reactions caused by antibodies to IgA. J Lab Clin Med 1975; 85, 838

Idsoe O. Gruthe T. Willcox R.R. DeWeck A.I. Nature and extent of penicillin sidereactions with particular reference to fatalities from anaphylactic shock. Bull W.H.O 1968; 38, 159

Stark B.J. Sullivan T.J. Biphasic and protracted anaphylaxis. J. Allergy Clin Immunol 1986; 78, 76–83

Siegel S.C. Heimlich E.M. Anaphylaxis. Ped Clin North Am 1962; 9, 29

Delange C. Irey N.S. Anaphylactic deaths, A clinicolpathologic study of 43 cases. J Forensic Sci 1972; 17, 525

Hunt E.L. Death from allergic shock. NEJM 1943; 228, 502

Squire J.R. The relationship between horse dandruff and horse serum antigens in asthma. Clin Sci 1950; 9, 127

Park W.H. Human hypersensitiveness to whole horse serum or serum globulins following diphtheria toxin antitoxin injections. J Immunol 1924; 9, 17

Davis H.M. Horse serum skin tests. J Hygiene 1938; 38, 325

Belin G.A. Norman P.S. Diagnostic tests in skin and serum of workers sensitized to Bacillus subtilis enzymes. Clin Allergy 1977; 7, 55

Dolovich J. Little D.C. Correlates of skin test reactions to Bacillus subtilis enzyme preparations. JACI 1972; 49, 43

Loprinzi C.L. Hennessee J. Tamsky L. Johnson T.E. Snake antivenin administration in a patient allergic to horse serum. South Med J 1983; 76, 501

Reisman R.E. Rose N.R. Witebsky E. Penicillin allergy and desensitization. J. Allergy 1962; 33, 178

Falleroni A.E. Treatment of allergic emergencies. Mod Treatment 1968; 5, 782

Casterline C.L. Evans R. Further studies on the mechanism of human histamine-induced asthma. J. Allergy Clin Immunol 1977; 59, 420

Drazen J.M. Venugolapan C.S. Soter N.A. H2 receptor mediated inhibition of immediate type hypersensitivity reaction in vivo. Amer Rev Respir Dis 1978; 117, 479

Kaliner M.A. Sigler R. Summers R. Shelhamer J.H. Effects of infused histamine: Analysis of H1 and H2 histamine receptor antagonists on cardiovascular and pulmonary response. J. Allergy Clin Immunol 1981; 68, 365

Kaliner M.A. Shelhamer J.H. Ottesen E.A. Effects of infused histamine: Correlation of plasma histamine levels and symptoms. J. Allergy Clin Immunol 1982; 69, 283

Myers G.E. Bloom F.L. Cimetidine combined with steroids and H1 antihistamines for the prevention of serious radiographic contrast media reactions. Cathet Cardiovasc Diag 1981; 7, 65

Bielory L. Kaliner M.A. Anaphylactoid reactions to radiocontrast materials. Intern Anesth Clin 1985; 23, 97

Axeinow L. 683 Falle von Serumkrankheit. Jahrbu Kinder 1913; 78, 565

Iga F. Ueber Herdreaktionen an den unberuhretn Augen nach parenteraler Zufuhr von artfremden Serum. Klin Monatsbl Augenheilkd 1930; 84, 449

Kojis F.G. Serum sickness and anaphylaxis: Analysis of cases of 6,211 patients treated with horse serum for various infections. Am J Dis Child 1942; 64(93), 313

Ratner F. Allergy Anaphylaxis and Immunotherapy: Basic Principles and Practice . Baltimore: Williams and Wilkins, 1943

Dixon F.J. Vazquez J.J. Weigle W.O. Cochrane G.C. Pathogenesis of serum sickness. Arch Path 1958; 65, 18

Sherman W.B. Serum sickness – 1957. Int Arch Allergy 1958; 12, 59

Reynolds J.S. Serum sickness: An old problem with new implications. Ann Allergy 1966; 24, 337

Bielory L. Gascon P. Lawley T.J. Frank M.M. Young N.S. Serum sickness from antithymocyte globulin administration. In: Young N.S. Levine A.S. Humphries K.J. eds. Aplastic Anemia: Stem Cell Biology and Advances in Treatment , New York: Alan R. Liss, 1984, ii–iii

Lawley T.J. Bielory L. Gascon P. Yancey K.B. Young N.S. Frank M.M. A prospective clinical and immunologic analysis of patients with serum sickness. N. Engl J Med 1989; 311, 1407

Bielory L. Gascon P. Lawley T.J. Young N.S. Frank M.M. Human serum sickness: A prospective clinical, immunological and immunopathological analysis of 35 patients treated with antithymocyte globulin. Medicine 1988; 67, 40–57

Longcope W.T. Serum sickness and analogous reactions from certain drugs, particularly the sulphonamides. Medicine 1943; 22, 521

Deswarte R.D. Drug allergy. In: Patterson R. ed. Allergic Diseases Diagnosis and Management , Philadelphia: Lippincott, 1980, 452

Corrigan P. Russell F.E. Wainschel T. Clinical reactions to antivenin. In: Rosenberg P. ed. Toxins: Animal, plant and microbiology , Oxford: Pergamon Press, 1978, 457

Gewurz H. Pickering R.J. Moberg A. Simmons R.L. Good R.A. Najarian J.S. Reactivities to horse anti-lymphocyte globulin. Int Arch Allergy 1970; 39, 210

Lance E.M. Medawar P.B. Taub R.N. Antilymphocyte serum. Adv Immunol. 1973; 17, 1

Hosty T.S. Hunter F.R. Incidence of reactions to antirabies horse serum. Public Health Rep 1953; 68, 789

Toogood J.H. Allergic reactions to antitetanus serum. Can Med J 1960; 82, 907

Karliner J.S. Belaval G.S. Incidence of reactions following administration of antirabies serum: Study of 526 cases. JAMA 1965; 193, 350

MacKenzie G.M. Hanger F.M. Serum disease and serum accidents. JAMA 1930; 94, 260

Hartung C. Die Serumexantheme bei Diphtheric. Jahrb Kinderh 1896; 42, 72

Moynihan N.H. Serum sickness and local reactions in tetanus prophylaxis: A study of 400 cases. Lancet 1955; 2, 264

Sullivan R. Past, present and future immunotherapy in snake venom poisoning. Ann Emerg Med 1987; 16, 938–944

Bielory L. Yancey K.B. Young N.S. Frank M.M. Lawley T.J. Cutaneous manifestations of serum sickness in patients antithymocyte globulin. J. Amer Acad Dermatol 1985; 85, 411

Lawley T.J. Bielory L. Gascon P. Yancey K.B. Young N.S. Frank M.M. A study of human serum sickness. J. Invest Dermatol 1985; 85, 1295

Gower R.G. Sausker W.I. Kohler P.F. Thorne G.E. Mclntosh R.M. Small vessel vasculitis and HBsAG. J. Allergy Clin Immunol 1978; 62, 222

Andrews B.S. Cains G. Mclntosh J. Petts V. Penny R. Circulating and tissue immune complexes in cutaneous vasculitis. J Clin Lab Immunol 1979; 1, 311

Braverman I.M. Yen A. Demonstration of immune complexes in spontaneous and histamine-induced lesions and in normal skin of patients with leukocytoclastic angiitis. J Invest Derm 1975; 64, 105

Boots R.H. Swift H.F. The arthritis of serum sickness. JAMA 1923; 80, 12

Weaver G.H. Serum disease. Arch Int Med 1909; 3, 485

Clarkson S.B. Kimberly R.P. Valinsky J.E. Nachman R.L. Unkeless J.C. Blockade of clearance of immune complexes by anti-Fe gamma receptor monoclonal antibody. J Exp Med 1986; 164, 474–489

Atkinson J.P. Frank M.M. Studies on the in vivo antibody and complement in the immune clearance of and destruction of erythrocytes in man. J Clin Inv 1914; 54, 339

Frank M.M. Hamburger M.I. Lawley T.J. Kimberley R.P. Plotz P.H. Defective reticuloendothelial system Fc-Receptor function in systemic lupus erythematosus. N Engl J Med 1979; 300, 518

Clark E. Kaplan B.I. Endocardial, arterial and other parenchymal alterations associated with serum disease in man. Arch Path 1937; 24, 548

Van Zandt Hawn C. Janeway C.A. Histological and serological sequences in experimental hypersensitivity. J Exp Med 1947; 85, 571

Hermitte J. Hagueneau L. Paralysies postserotherapiques et maladie du serum. Rev Neurol 1931; 38, 347

Cutter R.D. Auditory nerve involvement after tetanus antitoxin: First reported case. JAMA 1936; 106, 1006

Bennett A.E. Horse serum neuritis. JAMA 1939; 112, 590

Bardenwerper H.W. Serum neuritis from tetanus antitoxin. JAMA 1962; 179, 763

Brown L. Ocular manifestations of serum sickness. Amer J Ophthalmol 1915; 8, 614

Mason V.R. Optic neuritis in serum sickness. JAMA 1992; 78, 88

Bedell A.J. Stereoscopic fundus photography. JAMA 1935; 105, 1502

Wong V.G. Anderson R.R. McMaster P.R.B. Endogenous immune uveitis: The role of serum sickness. Arch Ophth 1971; 85, 93

Dixon F.J. Feldman J.D. Vasquez J.J. Experimental glomerulonephritis. The pathogenesis of a lab model resembling the spectrum of human glomerulonephritis. J Exp Med 1961; 113, 899

Unanue E.R. Dixon F.J. Experimental glomerulonephritis: Immunological events and pathogenetic mechanisms. Adv Immunol 1967; 6, 1

Bartolotti S.R. Peters D.K. Delayed removal of renal-bound antigen in decomplemented rabbits with acute serum sickness. Clin Exp Immunol 1978; 32, 199

Kashiwagi N. Brantigan C.O. Brettschneider L. Groth C.G. Starzl T.E. Clinical reactions and serologic changes after the administration of heterologous antilymphocyte globulin to human recipients of renal homografts. Ann Int Med 1968; 68, 275

Pincus T. Haberkern R. Christian C.L. Experimental chronic glomerulitis. J Exp Med 1968; 127, 819

Guinon L. Un Cas d’anguine membraneuse par le serum de roux; mort avec anurie et convulsions uremiques. Semaine Medicate 1895 300

De La Pava S. Nigogosyan G. Pickren J.W. Fatal glomerulonephritis after receiving horse anti-human-cancer serum: Report of 3 cases. Arch Int Med 1962; 109, 391

Ley D.C.H. Fitzgerald J.D.L. Changes in white blood cell and bone marrow morphology and serum protein fractions in induced and spontaneous hypersensitivity states. J. Allergy 1957; 28, 220

Schmidt J.J. Robinson J.H. Pennypacker C.S. Peripheral plasmacytosis in serum sickness. Ann Intern Med 1963; 59, 542

Barnett E.V. Stone G. Swisher S.N. Serum sickness and plasmacytosis: clinical, immunology and hematologic analysis. Amer J Med 1963; 35, 113

Bryant N. Laboratory immunology and serology. in: The Serological Diagnosis of Infectious Recommendations . Philadelphia, W.B: Saunders, 1979: 77–79

Davidson I. Heterophile antibodies in serum sickness. J Immunol 1929; 16, 259

Gormsen H. Heinzelman F. Behavior of sedimentation reaction serum proteins in serum sickness. Nord Med 1941; 11, 2125

Longcope W.T. Rackemann F.M. Relation of circulating antibodies to serum disease. J Exp Med 1918; 27, 341

Longcope W.T. MacKenzie G.M. The relation between the disappearance of foreign proteins from circulation and the formation of antibodies. Proc Soc Exp Bio Med 1920; 17, 133

Reisman R.E. Rose N.R. Witebsky E. Arbesman C.E. Serum sickness: II. Demonstration and characteristics of antibodies. J Allergy 1961; 32, 531

Bielory L. Gascon P. Lawley T.J. Frank M.M. Young N.S. Kaliner M.A. Immunoglobulin levels during serum sickness from antithymocyte globulin. J Allergy Clin Immunol 1984; 73, 154a

Bielory L. Brown E. Lawley T.J. Kaliner M.A. Young N.S. Frank M.M. Human serum sickness: Serological changes. Ann Allergy 1985; 54, 344a

Bielory L. Kemeny D.M. Richards D. Lessoff N.H. IgG subclass antibody production in human serum sickness. JACI 1990; 85, 573

Bielory L. Serum Sickness. In: Gellis S. Kagan B. eds. Current Pediatric Therapy . 12th ed. Philadelphia: W.B. Saunders, 1986, 638

Kniker W.T. Guerra F.A. Richards S.E.M. Prevention of immune complex disease (serum sickness) by antagonists of vasoactive amines. Pediatr Res 1971; 5, 381